Evidence map›Paper›PMID 32878268›Full record

ArticleInternational journal of molecular sciences2020

The Lysine Specific Demethylase-1 Negatively Regulates the

Anne-Laure Durand, Alexandre Dufour, Elisabeth Aubert-Foucher, Christine Oger-Desfeux, Marielle Pasdeloup, Sebastien Lustig, Elvire Servien, Gualter Vaz, Emeline Perrier-Groult, Frederic Mallein-Gerin and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Anne-Laure DurandCNRS UMR 5305 Laboratory of Tissue Biology and Therapeutic Engineering, Université Claude Bernard Lyon1, Univ Lyon, 69367 Lyon, France.
Alexandre DufourCNRS UMR 5305 Laboratory of Tissue Biology and Therapeutic Engineering, Université Claude Bernard Lyon1, Univ Lyon, 69367 Lyon, France.
Elisabeth Aubert-FoucherCNRS UMR 5305 Laboratory of Tissue Biology and Therapeutic Engineering, Université Claude Bernard Lyon1, Univ Lyon, 69367 Lyon, France.
Christine Oger-DesfeuxPRABI-AMSB, Batiment Mendel, Campus de la Doua, Université Claude Bernard Lyon1, University Lyon, 69622 Villeurbanne CEDEX, France.
Marielle PasdeloupCNRS UMR 5305 Laboratory of Tissue Biology and Therapeutic Engineering, Université Claude Bernard Lyon1, Univ Lyon, 69367 Lyon, France.
Sebastien LustigFIFA Medical Center of Excellence Orthopaedic Surgery and Sports Medicine Department, Croix-Rousse Hospital, Hospices Civils de Lyon, 103 grande rue de la Croix-Rousse 69317 Lyon CEDEX 04, France and IFSTTAR, LBMC UMR_T9406 Univ Lyon, Claude Bernard Lyon 1 University, 69317 Lyon, France.
Elvire ServienFIFA Medical Center of Excellence, Orthopaedic Surgery and Sports Medicine Department, Croix-Rousse Hospital, Hospices Civils de Lyon, 103 grande rue de la Croix-Rousse 69317 Lyon CEDEX 04, France; LIBM-EA 7424, Interuniversity Laboratory of Biology of Mobility, Claude Bernard Lyon 1 University, 69317 Lyon, France.
Gualter VazOrthopaedic Surgery Department, CMCR les Massues, Croix rouge française, 92 rue Edmond Locard, 69005 Lyon, France.
Emeline Perrier-GroultCNRS UMR 5305 Laboratory of Tissue Biology and Therapeutic Engineering, Université Claude Bernard Lyon1, Univ Lyon, 69367 Lyon, France.
Frederic Mallein-GerinCNRS UMR 5305 Laboratory of Tissue Biology and Therapeutic Engineering, Université Claude Bernard Lyon1, Univ Lyon, 69367 Lyon, France.ORCID 0000-0001-6177-6273
Jerome E LafontCNRS UMR 5305 Laboratory of Tissue Biology and Therapeutic Engineering, Université Claude Bernard Lyon1, Univ Lyon, 69367 Lyon, France.
Université Claude Bernard Lyon 1 · FRHôpital de la Croix-Rousse · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteoarthritis (OA) is a degenerative disease of the joints which is associated with an impaired production of the cartilage matrix by the chondrocytes. Here, we investigated the role of Lysine-Specific Demethylase-1 (LSD1), a chromatin remodeling enzyme whose role in articular chondrocytes was previously associated with a catabolic activity and which is potentially involved during OA. Following a loss of function strategy and RNA sequencing analysis, we detail the genes which are targeted by LSD1 in human articular chondrocytes and identify

Indexed as

Gene Expression RegulationAdultAgedAged, 80 and overCartilage, ArticularCase-Control StudiesCells, CulturedChondrocytesCollagen Type IXHistone DemethylasesHumansLysineMiddle AgedOsteoarthritisPromoter Regions, GeneticCOL9A1 protein, humanCollagen Type IXHistone DemethylasesKDM1A protein, humanLysinearticular chondrocyteslysine demethylaseosteoarthritistype IX collagen

Identifiers

PMID32878268
PMCPMC7504057
OpenAlexW3081543323

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.